Clinical
Follow pivotal data releases and trial developments that create new strategic pressure for biotech and pharma operators.
11 signals
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.
CLINICAL
The inVitD Trial aims to assess the effects of vitamin D supplementation on menstrual cycle hormones in women aged 19-40.
CLINICAL
A Phase 2/3 study is evaluating zilovertamab vedotin in combination with standard care for rrDLBCL, with a protocol amendment discontinuing enrollment in one cohort.
CLINICAL
AUR103 calcium is being evaluated in Phase 2 study for efficacy and safety in advanced neuroendocrine tumors.
CLINICAL
A Phase II study is assessing the outcomes of stopping BTK inhibitor therapy in CLL patients in remission for over two years.
CLINICAL
A phase II trial is underway to compare the efficacy and safety of FOLFOX8 versus mFOLFOX6 with bevacizumab or cetuximab in patients with unresectable metastatic colorectal cancer.
CLINICAL
A Phase 2/3 study is evaluating CMP-001 in combination with nivolumab against nivolumab monotherapy in advanced melanoma.
CLINICAL
Roche will present new Phase II data for enicepatide and petrelintide in obesity at the ADA Scientific Sessions.
COMPETITIVE
Roche will present new data from the Phase II studies of enicepatide and petrelintide in obesity at the ADA Scientific Sessions.
COMPETITIVE
Roche presented late-breaking Phase II data showing significant efficacy and safety for enicepatide and petrelintide in weight management.
CLINICAL
A Phase II clinical trial is underway to evaluate the efficacy and safety of SAL0140 at varying doses in patients with primary aldosteronism.
CLINICAL
A Phase II trial is underway to evaluate the efficacy of venetoclax combined with rituximab in older patients with untreated mantle cell lymphoma.
Showing 1–11 of 11 records